-+ 0.00%
-+ 0.00%
-+ 0.00%

Grail to present late-breaking NHS-Galleri trial results at ASCO 2026

PUBT·04/21/2026 20:54:23
Listen to the news
Grail to present late-breaking NHS-Galleri trial results at ASCO 2026
  • Grail set late-breaking oral presentations at 2026 ASCO Annual Meeting in Chicago, May 29-June 2, 2026, for new data from NHS-Galleri trial and final results from PATHFINDER 2.
  • NHS-Galleri results will be presented in the future, expanding on topline findings announced in February 2026 that indicated earlier-stage detection and fewer late-stage cancer diagnoses with Galleri added to standard screening.
  • PATHFINDER 2 complete dataset will be presented in the future, building on results previously presented in October 2025 that showed Galleri increased cancer detection when used alongside guideline-recommended screenings.
  • Grail highlighted enrollment of more than 174,000 participants across both studies, positioning the evidence package to support broader adoption of its Galleri multi-cancer early detection blood test.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604211653PR_NEWS_USPR_____LA39960) on April 21, 2026, and is solely responsible for the information contained therein.